Sisram Med (01696) announced interim results
- RevenueUS$1.7bn
- Net profitUS$1.1M
- Profit attributable to ownersUS$-1.2M
- Revenue YoY+3.6%
- Net profit YoY-88.3%
- Depreciation & amortisationHK$1.2bn
- Capital expenditureHK$-18.1M
- Interest-bearing debtHK$3.6bn
Source Sisram Med



